Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3357920
Max Phase: Preclinical
Molecular Formula: C10H12N4O7
Molecular Weight: 300.23
Molecule Type: Small molecule
Associated Items:
ID: ALA3357920
Max Phase: Preclinical
Molecular Formula: C10H12N4O7
Molecular Weight: 300.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)OCCOCn1c(=O)n(C)c(=O)c2c1no[n+]2[O-]
Standard InChI: InChI=1S/C10H12N4O7/c1-6(15)20-4-3-19-5-13-8-7(14(18)21-11-8)9(16)12(2)10(13)17/h3-5H2,1-2H3
Standard InChI Key: NKIIWGIIJRXHRY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.23 | Molecular Weight (Monoisotopic): 300.0706 | AlogP: -2.14 | #Rotatable Bonds: 5 |
Polar Surface Area: 132.50 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -2.14 | CX LogD: -2.14 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.35 | Np Likeness Score: -0.51 |
1. Xu X, Wang J, Yao Q.. (2015) Synthesis and quantitative structure-activity relationship (QSAR) analysis of some novel oxadiazolo[3,4-d]pyrimidine nucleosides derivatives as antiviral agents., 25 (2): [PMID:25515560] [10.1016/j.bmcl.2014.11.065] |
Source(1):